June 2015

Cardio-Oncology: The Intersection Between Cancer and Cardiovascular Disease

May 26, 2015

Evidence-Based Oncology

With the prognosis for many cancers improving, we are seeing an appropriate sharpening of focus on the cardiovascular risks of patients who have survived cancer or are being treated for cancer, as well as a growing recognition of the impact this competing morbidity has on both short- and long-term health outcomes.

Extending Cancer Care Past Remission: The Importance of Cardiac Toxicity Monitoring and Awareness

May 27, 2015

Evidence-Based Oncology

Medical monitoring and counseling can help us track and contain many harmful effects of cancer drug-induced cardiotoxicity. Patient engagement from the very beginning, along with medically advanced testing methods, can help us surmount cardiotoxicity and better ensure that patients receive only the benefits of essential cancer treatment.

Radiation Therapy and Cardiotoxicity: A Cancer Survivor's Story

May 26, 2015

Evidence-Based Oncology

A patient advocate underscores the need for awareness and self-advocacy among cancer patients by highlighting her own experience as a survivor, who experienced delayed cardiotoxic effects of chemotherapy.

Importance of a Heart Failure Disease Management Program for Chemotherapy-Induced Toxicity

May 27, 2015

Evidence-Based Oncology

To promote collaboration and efficiency, the MD Anderson Cancer Center developed an interdisciplinary team—based Heart Success Program to coordinate the management of concurrent cardiomyopathy and HF while the patient is receiving cancer treatment.

Influence of Cardiotoxic Risk on Treatment Choice in Adult Cancers

May 26, 2015

Evidence-Based Oncology

With the explosion of new therapies in cancer care, the risk of each new therapy must be clearly understood prior to making treatment decisions with patients. Data from clinical trials alone are insufficient to educate these treatment choices, and real-world evidence from higher-risk populations should be generated to inform these treatment decisions.

Cardiovascular Side Effects of Cancer Treatment Demand Attention

May 27, 2015

Evidence-Based Oncology

Improved survivorship rates among cancer patients has brought a growing awareness of a serious latent impact of chemotherapy and radiation: cardiotoxicity. Despite extensive research on the subject, our understanding of the tools for identifying and preventing these complications is limited.

Advancing Patient Care in Cardio-Oncology: The ACC.15 Cardio-Oncology Intensive

June 02, 2015

Evidence-Based Oncology

A Cardio-Oncology Working Group formed by the ACC conducted a nationwide survey focused on cardio-oncology services, gathering opinions from cardiovascular division chiefs and fellowship training directors. This helped identify important challenges, including the need for broader educational opportunities and training.

In Conversation With a Cardiologist: Anju Nohria, MD

June 02, 2015

Evidence-Based Oncology

Anju Nohria, MD, assistant professor, Harvard Medical School, spoke to Evidence-Based Oncology about some of the challenges clinicians face with monitoring cardiovascular risks in cancer patients.

Value of Patient-Reported Outcomes in Oncology Care

June 02, 2015

Evidence-Based Oncology

To discuss patient-reported outcomes and their importance in patient-centered care, The American Journal of Managed Care convened a panel of healthcare experts to participate in the Oncology Stakeholders Summit, Spring 2015 Peer Exchange.

Experts Discuss Medicare's New Oncology Care Model

June 02, 2015

Evidence-Based Oncology

The American Journal of Managed Care convened experts in health policy, from health plans, and from community oncology, to discuss OCM and other issues in oncology care during the Oncology Stakeholders Summit, Spring 2015 Peer Exchange.

Augmenting the Immune System to Achieve Great Outcomes in Cancer Care

June 03, 2015

Evidence-Based Oncology

During the session "Principles of Immunotherapy" at the National Comprehensive Cancer Network 20th Annual Conference in Hollywood, Florida, Anthony J. Olszanski, RPh, MD, from the Fox Chase Cancer Center, described the complex interplay between the immune system and cancer.

Defining Value in Cancer Care Treatment

June 03, 2015

Evidence-Based Oncology

Participants on the second day of the National Comprehensive Cancer Network 20th Annual Conference in Hollywood, Florida, March 12-14, 2015, spent a long time defining value in cancer care and how it can be incorporated into healthcare decision making.

20 Years of Creating and Embracing Guidelines in Cancer Care

June 03, 2015

Evidence-Based Oncology

On the first day of the NCCN 20th Annual Conference in Hollywood, Florida, March 12-14, 2015, panelists took a look back at the last 20 years of the NCCN and why it succeeded when others had failed before.

Preventing Anthracycline-Related Late Cardiac Effects in Childhood Cancer Survivors

June 08, 2015

Evidence-Based Oncology

In the United States, where 1 in 680 people between 20 and 50 years old are survivors of childhood cancer, the impact of long-term health consequences is a cause for concern, and even more so because this population is increasing.